NOX-A12 (olaptesed pegol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NOX-A12 (olaptesed pegol), covering 2025-06-25 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients [Phase 1, Phase 2]